Novel phenotype of achondroplasia due to biallelicFGFR3pathogenic variants
- 16 July 2018
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 176 (7) , 1675-1679
Abstract
Pathogenic variants in the fibroblast growth factor receptor 3 (FGFR3) gene are responsible for a broad spectrum of skeletal dysplasias, including achondroplasia (ACH). The classic phenotype of ACH is caused by two highly prevalent mutations, c.1138G > A and c.1138G > C (p.Gly380Arg). In the homozygous state, these variant results in a severe skeletal dysplasia, neurologic deficits, and early demise from respiratory insufficiency. Although homozygous biallelic mutations have been reported in patients with ACH in combination with hypochondroplasia or other dominant skeletal dysplasias, thus far, no cases of heterozygous biallelic pathogenic ACH‐related variants inFGFR3have been reported. We describe a novel phenotype of an infant with two ACH‐related mutations inFGFR3, p.Gly380Arg and p.Ser344Cys. Discordant features from classic ACH include atypical radiographic findings, severe obstructive sleep apnea, and focal, migrating seizures. We also report the long‐term clinical course of her father, who harbors the p.Ser344Cys mutation that has only been reported once previously in a Japanese patient. The phenotype of heterozygous biallelic mutations inFGFR3associated with ACH is variable, underscoring the importance of recognition and accurate diagnosis to ensure appropriate management.Keywords
Funding Information
- National Institutes of Health (T32GM007454)
- Clinical Center
This publication has 31 references indexed in Scilit:
- Weight for age charts for children with achondroplasiaAmerican Journal of Medical Genetics Part A, 2007
- FGFR3 Mutations and Medial Temporal Lobe Dysgenesis Lobe DysgenesisJournal of Child Neurology, 2007
- Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen‐activated protein kinase activationJournal of Neurochemistry, 2006
- FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic developmentDevelopmental Biology, 2005
- Double heterozygosity in bone growth disorders: Four new observations and reviewAmerican Journal of Medical Genetics Part A, 2003
- A Novel Skeletal Dysplasia with Developmental Delay and Acanthosis Nigricans Is Caused by a Lys650Met Mutation in the Fibroblast Growth Factor Receptor 3 GeneThe American Journal of Human Genetics, 1999
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995
- Homozygous achondroplasia: Morphologic and biochemical study of cartilageAmerican Journal of Medical Genetics, 1990
- Achondroplasia‐hypochondroplasia complexAmerican Journal of Medical Genetics, 1987
- Standard growth curves for achondroplasiaThe Journal of Pediatrics, 1978